LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS UVPRO SPORT INVISIBLE SUNSCREEN BROAD SPECTRUM SPF 45- avobenzone, homosalate, octisalate, and octocrylene aerosol, spray

La Roche Posay Laboratoire Dermatologique ANTHELIOS UVPRO SPORT INVISIBLE SUNSCREEN BROAD SPECTRUM SPF 45 by

Drug Labeling and Warnings

La Roche Posay Laboratoire Dermatologique ANTHELIOS UVPRO SPORT INVISIBLE SUNSCREEN BROAD SPECTRUM SPF 45 by is a Otc medication manufactured, distributed, or labeled by L'Oreal USA, Inc., PLZ Corp. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredients

Avobenzone 3%

Homosalate 10%

Octisalate 5%

Octocrylene 7%

Purpose

Sunscreen

Uses

• helps prevent sunburn
• if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Flammable.

Avoid fire, flame and heat during application and until fully dry.

Do not use

on damaged or broken skin

When using this product

• keep out of eyes. Rinse with water to remove.
• keep away from face to avoid breathing it
• use only as directed in a ventilated area. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.
• do not puncture or incinerate. Contents under pressure. Do not store at temperatures above 120oF.

Stop use and ask a doctor if

rash occurs

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

• spray liberally and spread evenly by hand 15 minutes before sun exposure.
• hold container 4 to 6 inches from the skin to apply
• do not spray directly into face. 
• Spray on hands then apply to face. do not apply in windy conditions 
• use in a well-ventilated area 
• reapply: 
•     after 80 minutes of swimming or sweating 
•     immediately after towel drying 
•     at least every 2 hours  
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: 
• limit time in the sun, especially from 10 a.m. - 2 p.m. 
• wear long-sleeved shirts, pants, hats, and sunglasses 
• children under 6 months of age: Ask a doctor

Other information

protect the product in this container from excessive heat and direct sun

Inactive ingredients

alcohol denat., isopropyl myristate, dicaprylyl carbonate, diisopropyl sebacate, ethylenediamine/stearyl dimer dilinoleate copolymer, caprylic/capric triglyceride, citric acid, diethylhexyl syringylidenemalonate, glycine soja (soybean) oil, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, pentylene glycol, tocopherol, trisodium ethylenediamine disuccinate, water

Questions or comments?

1-888-LRP-LABO 1-888-577-5226

Monday - Friday (9 a.m. - 5 p.m. EST)

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS UVPRO SPORT INVISIBLE SUNSCREEN BROAD SPECTRUM SPF 45 
avobenzone, homosalate, octisalate, and octocrylene aerosol, spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82046-632
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	30 mg  in 1 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	100 mg  in 1 g
OCTISALATE (UNII: 4X49Y0596W) (ETHYLHEXYL SALICYLATE - UNII:4X49Y0596W)	OCTISALATE	50 mg  in 1 g
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	70 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
ALCOHOL (UNII: 3K9958V90M)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
DICAPRYLYL CARBONATE (UNII: 609A3V1SUA)
DIISOPROPYL SEBACATE (UNII: J8T3X564IH)
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
DIETHYLHEXYL SYRINGYLIDENEMALONATE (UNII: 3V5U97P248)
SOYBEAN OIL (UNII: 241ATL177A)
PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE (UNII: 255PIF62MS)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
TOCOPHEROL (UNII: R0ZB2556P8)
TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82046-632-01	122 g in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	03/06/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	03/06/2026

Labeler - L'Oreal USA, Inc. (002136794)

Establishment
Name	Address	ID/FEI	Business Operations
PLZ Corp		203350785	manufacture(82046-632)